Prof Silvia Marino

Silvia Marino

Professor of Neuropathology

Blizzard Institute - Centre for Genomics for Child Health
Queen Mary University of London

Research

Brain Cancer, Epigenetics, 3D models, organoids

Cancer Models, Neuronal Models

Interests

We have established cerebral organoid models derived from expanded potential stem cells (EPSCs) and developed robust protocols to achieve region specific differentiation, including forebrain, cerebellum, and midbrain/pons identities. These models have been extensively characterised using single cell transcriptomic profiling and bulk epigenetic analyses. By leveraging similarly well annotated collections of human brain tissue, we have been able to accurately stage our organoids developmentally and assess the fidelity with which they recapitulate key features of the human brain.
We have further demonstrated that progenitor populations within these organoids can be genetically engineered to initiate tumourigenesis, and that primary human brain tumour cells can be co cultured with organoids to model tumour growth within a relevant microenvironmental niche. Building on this foundation, we are now interested in exploring how these organoid platforms could be further developed and scaled to enable high throughput CRISPR based genetic screens and compound screening approaches.

Publications of specific relevance to Predictive in vitro Models

solid heart iconPublications of specific relevance to Predictive in vitro Models

2025

MDB-13. Modelling medulloblastoma pathogenesis and treatment in human cerebellar organoids
Willott T, Nicholson JG, Xiao Y, Ogunbiyi O, Mistry T, Zabet NR, Merve A, Badodi S et al.
Neuro-Oncology Pediatrics, Oxford University Press (Oup) vol. 1 (Supplement_1) 
01-08-2025
Disruption of DNA methylation underpins the neuroinflammation induced by targeted CNS radiotherapy
Millner TO, Panday P, Xiao Y, Nicholson JG, Boot JR, Arpe Z, Stevens PA, Rahman NN et al.
Brain, Oxford University Press (Oup) vol. 148 (9), 3137-3152.  
29-04-2025
A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities
Lucchini S, Nicholson JG, Zhang X, Househam J, Lim YM, Mossner M, Millner TO, Brandner S et al.
Embo Molecular Medicine, Springer Nature vol. 17 (6), 1325-1354.  
28-04-2025
Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets
Vinel C, Boot J, Jin W, Pomella N, Hadaway A, Mein C, Zabet NR, Marino S
Bmc Biology, Springer Nature vol. 23 (1) 
07-02-2025

2024

Lineage specification in glioblastoma is regulated by METTL7B
Constantinou M, Nicholson J, Zhang X, Maniati E, Lucchini S, Rosser G, Vinel C, Wang J et al.
Cell Reports, Elsevier vol. 43 (6) 
01-06-2024

2022

Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape
Boot J, Rosser G, Kancheva D, Vinel C, Lim YM, Pomella N, Zhang X, Guglielmi L et al.
Elife, Elife vol. 11 
22-11-2022
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
Badodi S, Pomella N, Lim YM, Brandner S, Morrison G, Pollard SM, Zhang X, Zabet NR et al.
Neuro-Oncology, Oxford University Press (Oup) vol. 24 (8), 1273-1285.  
25-02-2022

2021

Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma
Vinel C, Rosser G, Guglielmi L, Constantinou M, Pomella N, Zhang X, Boot JR, Jones TA et al.
Nature Communications, Springer Nature vol. 12 (1) 
21-10-2021
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation
Badodi S, Pomella N, Zhang X, Rosser G, Whittingham J, Niklison-Chirou MV, Lim YM, Brandner S et al.
Nature Communications, Springer Nature vol. 12 (1) 
12-04-2021
Harnessing brain development to understand brain tumours
Marino S, Gilbertson RJ
Development, The Company of Biologists vol. 148 (2) 
15-01-2021

2020

Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
Dumas AA, Pomella N, Rosser G, Guglielmi L, Vinel C, Millner TO, Rees J, Aley N et al.
The Embo Journal, Springer Nature vol. 39 (15) 
22-06-2020

Grants

solid heart iconGrants of specific relevance to Predictive in vitro Models
bullet iconLeveraging the enhancer landscape for precision medicine in glioblastoma
Nicolae Radu Zabet and Silvia Marino
£501,379 Barts and the London Charity
01-05-2026 - 30-04-2029
bullet iconBrain Tumour Research Centre
Silvia Marino, Sara Badodi, Nicolae Radu Zabet, Lovorka Stojic and Sindhuja Sridharan
£2,709,922 Brain Tumour Research
01-10-2024 - 04-01-2030
bullet iconEstablishment of a Brain Tumour Research Centre of Excellence
Silvia Marino
£4,753,541 Brain Tumour Research
01-08-2024 - 31-07-2027
bullet iconTackling epigenetic deregulation in medulloblastoma and DIPG
Silvia Marino
£250,000 Ali's Dream
01-03-2023 - 28-02-2027
bullet iconBarts Brain Tumour Centre - Basic Science
Silvia Marino
£1,729,566 Barts and the London Charity
01-01-2019 - 31-10-2026


bullet iconCharacterising the tumour-muscle crosstalk to develop novel treatments for glioblastoma
Silvia Marino and Claire Vinel
£225,000 Brain Tumour Charity, The
01-04-2023 - 31-03-2026
bullet iconOn-Demand Targeted RNA Delivery Nanotheranostics for Glioblastoma Treatment
Silvia Marino and Julien Gautrot
£184,106 Barts and the London Charity
01-03-2023 - 01-04-2026
bullet iconA role of seizures in progression of Glioblastoma multiforme
Silvia Marino
£30,000 AMS Academy of Medical Sciences
08-09-2021 - 31-08-2024
bullet iconClinical Lecturer Speciality Trainee Placement in Neurosurgery ST4
Silvia Marino
£238,025 HEE Health Education England
01-03-2020 - 31-08-2024
bullet iconInvestigating regional heterogeneity and progression-associated markers in oligodendrogliomas
Thomas Millner and Silvia Marino
£47,146 Pathological Society Of Great Britain And Ireland
01-03-2020 - 01-12-2023
bullet iconClinical Lecturer Speciality Trainee Placement in Diagnostic Neuropathology
Silvia Marino
£323,097 HEE Health Education England
24-02-2020 - 23-02-2024
bullet iconA novel epigenetic discovery pipeline for patient-tailored drug monitoring in glioblastoma
Silvia Marino and Trevor Graham
£1,476,460 CR-UK Cancer Research UK
01-01-2020 - 10-05-2026
bullet iconEpigenetic Regulation of Ephrin A5 by BMI1 in human Gliomas
Silvia Marino
£4,000 Barts and the London Charity
01-02-2018 - 31-01-2019
bullet iconNIHR IAT - Clinical Research Lectureships
Silvia Marino
£200,000 MCSBHT Medical College of St Bartholomew's Hospital Trust
01-10-2017 - 30-06-2024
bullet iconA BMI1/CHD7 signature in medulloblastoma with poor prognosis
Silvia Marino
£400,933 Medical Research Council
01-12-2015 - 31-01-2019
bullet iconPhd studentship-Regulation of inflammatory pathways in microglia the innate immune cells of the brain
Silvia Marino
£85,656 Willoughby Trustees
01-10-2015 - 31-12-2019
bullet iconMetabolic analysis of the tumour suppressor protein p73 in medulloblastoma- Paul O'Gorman Post-doctoral Research Fellowship
Silvia Marino
£382,077 Children with Cancer UK
01-09-2014 - 29-02-2020